Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole

Clinical trial NCT03092193 · COMPLETED

Trial details

NCT number: NCT03092193
Sponsor: University of Sao Paulo
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant

Start date: 2017-03-01
Primary completion: 2017-10-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.